DNA X, Inc. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
DNA X, Inc. filed Form 8-K on 2026-08-27 reporting Item 5.02 (departure/appointment of officers and compensatory arrangements). The filing header indicates this concerns officer compensation but the actual document text with specific counterparty names, dollar amounts, share counts, vesting terms, or dates is not provided in the submission excerpt.
Why this rating
Routine officer compensation disclosure with no quantified terms disclosed here; cannot assess materiality without specific amounts or percentages relative to $12.6M market cap.
Extracted items
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.